Detalhe da pesquisa
1.
Diagnostic Performance of Noninvasive Tests for Advanced Hepatic Fibrosis in Young Age Population.
Clin Gastroenterol Hepatol
; 21(7): 1831-1840.e12, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115504
2.
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure.
J Hepatol
; 74(2): 330-339, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781201
3.
A survey on the awareness, current management, and barriers for non-alcoholic fatty liver disease among the general Korean population.
Sci Rep
; 13(1): 15205, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37709931
4.
Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver disease.
Biol Direct
; 18(1): 50, 2023 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37626369
5.
ALS-L1023 from Melissa officinalis Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model.
Life (Basel)
; 13(1)2022 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36676050
6.
Regulation of Hepatocyte Nuclear Factor 4α Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease.
Life (Basel)
; 12(11)2022 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362837
7.
Reply to correspondence: "Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study".
Clin Mol Hepatol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768963
8.
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology.
Clin Mol Hepatol
; 29(2): 371-373, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916169